Literature DB >> 11400037

Late onset temporal lobe epilepsy with MRI evidence of mesial temporal sclerosis following acute neurocysticercosis: case report.

E Kobayashi1, C A Guerreiro, F Cendes.   

Abstract

UNLABELLED: The objective of this case report is to describe magnetic resonance imaging (MRI) evidence of mesial temporal sclerosis (MTS) in a patient with new onset temporal lobe epilepsy (TLE) and acute neurocysticercosis with multiple cysts. A 56 years old man with new onset headache, Simple Partial Seizures and Complex Partial Seizures underwent CT scan and lumbar puncture as diagnose proceeding. Multiple cysts and meningitis were identified, with a positive immunology for cysticercosis. Seizures were recorded over the left temporal region in a routine EEG. Treatment with albendazole was performed for 21 days, with clinical improvement and seizure remission after 4 months. An MRI scan 11 months after treatment, showed complete resolution of those cystic lesions and a left hippocampal atrophy (HA) with hyperintense T2 signal. The presence of HA and hyperintense T2 signal in this patient has not, to date, been associated with a poor seizure control.
CONCLUSIONS: This patient presented with MRI evidence of left MTS after new onset partial seizures of left temporal lobe origin. Although we did not have a previous MRI scan, it is likely that this hippocampal abnormality was due to the acute inflammatory response to cysticercosis associated to repeated partial seizures. This suggests that acute neurocysticercosis associated with repeated seizures may cause MTS and late onset TLE.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11400037     DOI: 10.1590/s0004-282x2001000200021

Source DB:  PubMed          Journal:  Arq Neuropsiquiatr        ISSN: 0004-282X            Impact factor:   1.420


  7 in total

1.  Calcified neurocysticercosis associates with hippocampal atrophy: a population-based study.

Authors:  Oscar H Del Brutto; Perla Salgado; Julio Lama; Victor J Del Brutto; Xavier Campos; Mauricio Zambrano; Héctor H García
Journal:  Am J Trop Med Hyg       Date:  2014-10-27       Impact factor: 2.345

Review 2.  Update on Cysticercosis Epileptogenesis: the Role of the Hippocampus.

Authors:  Oscar H Del Brutto; Jerome Engel; Dawn S Eliashiv; Hector H García
Journal:  Curr Neurol Neurosci Rep       Date:  2016-01       Impact factor: 5.081

3.  MRI findings in people with epilepsy and nodding syndrome in an area endemic for onchocerciasis: an observational study.

Authors:  A S Winkler; K Friedrich; S Velicheti; J Dharsee; R König; A Nassri; M Meindl; A Kidunda; T H Müller; L Jilek-Aall; W Matuja; T Gotwald; E Schmutzhard
Journal:  Afr Health Sci       Date:  2013-06       Impact factor: 0.927

4.  Calcified cysticercotic lesions and intractable epilepsy: a cross sectional study of 512 patients.

Authors:  T R Velasco; P A Zanello; C L Dalmagro; D Araújo; A C Santos; M M Bianchin; V Alexandre; R Walz; J A Assirati; C G Carlotti; O M Takayanagui; A C Sakamoto; J P Leite
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-04       Impact factor: 10.154

Review 5.  On the relationship between neurocysticercosis and mesial temporal lobe epilepsy associated with hippocampal sclerosis: coincidence or a pathogenic relationship?

Authors:  Marino Muxfeldt Bianchin; Tonicarlo Rodrigues Velasco; Antonio Carlos dos Santos; Américo Ceiki Sakamoto
Journal:  Pathog Glob Health       Date:  2012-09       Impact factor: 2.894

6.  Neurocysticercotic Calcifications and Hippocampal Sclerosis: A Case-Control Study.

Authors:  Mateus de Oliveira Taveira; Marcia Elisabete Morita; Clarissa Lin Yasuda; Ana Carolina Coan; Rodrigo Secolin; Alberto Luiz Cunha da Costa; Fernando Cendes
Journal:  PLoS One       Date:  2015-07-01       Impact factor: 3.240

7.  Evaluating the Association of Calcified Neurocysticercosis and Mesial Temporal Lobe Epilepsy With Hippocampal Sclerosis in a Large Cohort of Patients With Epilepsy.

Authors:  Thaís Leite Secchi; Rosane Brondani; José Augusto Bragatti; Jorge Wladimir Junqueira Bizzi; Marino Muxfeldt Bianchin
Journal:  Front Neurol       Date:  2022-01-27       Impact factor: 4.003

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.